If You Invested $1,000 in SpaceX at Its IPO, Here Is What It Is Worth Today

SpaceX IPO momentum has cooled, with investors warned the AI-driven upside will likely take years to monetize. Despite projected progress (Reuters: orbital AI infrastructure test demonstrations could start by end-2027), the stock’s $2.1T market cap on $18.6B of 2025 revenue implies a ~112x price-to-sales multiple, which the article says may weigh on near-term returns.

Analysis

This is less a near-term earnings catalyst than a duration test. The market is being asked to pay venture-style multiples for an asset whose AI monetization is still in pre-commercial infrastructure mode; that usually compresses multiples once the first wave of enthusiasm fades and the next hard milestone slips by a quarter or two. The key issue is not whether the AI story is real, but whether anything financially material arrives before the stock’s scarcity premium decays.

The second-order implication is that the most obvious beneficiaries of any real AI spending are still the picks-and-shovels names with visible demand today, not the platform story with years of capex ahead. If investors rotate away from speculative AI optionality, high-quality monetizers like NVDA should be relatively insulated because their revenue conversion is immediate and repeatable, while SPCX must keep funding a very long-dated roadmap. That creates a valuation gap that can persist for months even if the long-term narrative remains intact.

The main risk to a bearish stance is a credible proof point: a customer contract, a successful orbital demo, or any evidence that the AI infrastructure roadmap can be commercialized faster than expected. Absent that, the stock is vulnerable to “show me” trading over the next 1-3 months, with the structural overhang extending 6-18 months if execution keeps sliding. The contrarian view is that investors may be underestimating the option value of space-based compute, but that option is likely already embedded in the current price; the asymmetric error is paying too much for a very long-dated call.

Key Decisions for Investors

• Avoid initiating a fresh long in SPCX on momentum; wait 1-3 months for a pullback or a concrete commercialization update. Risk/reward is poor at a premium valuation unless there is verified revenue acceleration.
• Consider a relative-value short SPCX / long NVDA pair for 3-6 months. Thesis: NVDA monetizes AI capex now, while SPCX’s AI optionality is years away; downside is a faster-than-expected demo or contract announcement.
• If SPCX remains tightly held and borrow is expensive, use call spreads or downside puts rather than outright short exposure. Look for a 3-6 month structure tied to the next catalyst window; invalidation is a signed commercial milestone or launch success.
• Use SPCX weakness as a watchlist signal for broader speculative AI sentiment. If high-multiple, long-duration AI names begin to de-rate together, that would support rotating toward profitable AI infrastructure leaders and away from story stocks.